Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibody-Drug Conjugates (ADCs)
    (1)
  • ROR
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
TargetMol | Tags By Application
  • ELISA
    (2)
  • FCM
    (2)
  • Functional assay
    (2)
Filter
Search Result
Results for "

zilovertamab

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • ADC/ADC Related
    1
    TargetMol | All_Pathways
Zilovertamab
UC-961, Cirmtuzumab, 1643432-38-5
T767492485779-13-1
Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer.
  • $247
In Stock
Size
QTY
Zilovertamab vedotin
VLS-101, MK-2140
T77186
Zilovertamab vedotin is a novel antibody-drug conjugate (ADC) constructed by conjugating the humanized monoclonal antibody zilovertamab with the anti-microtubule cytotoxic drug monomethyl vedotin. It binds to ROR1 on the surface of tumor cells, promotes rapid internalization and trafficking of the complex to lysosomes, followed by ADC cleavage and release of monomethyl vedotin, thereby inducing tumor cell apoptosis. It can be used in cancer-related research.
  • $758
2-4 weeks
Size
QTY